Search

for
Search:

GlossaryDiphenylcyclopropenone (DCP)

topical immunotherapy agent used to treat alopecia areata

Diphenylcyclopropenone (DPCP) is a topical immunotherapy agent used primarily to treat alopecia areata, a condition that causes hair loss. It works by inducing a mild allergic reaction on the scalp, which is thought to distract the immune system from attacking hair follicles, thereby promoting hair regrowth.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 97 results

research Immediate and Delayed Complications of Dexamethasone Cyclophosphamide Pulse Therapy

20 citations, October 2003 in “The Journal of Dermatology”

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

research Alopecia Areata: Treatment of Today and Tomorrow

48 citations, June 2003 in “Journal of Investigative Dermatology Symposium Proceedings”

Contact sensitizers like DCP and SADBE are the most effective treatments for alopecia areata.

research Dermatitis Cruris Pustulosa Et Atrophicans Revisited: Our Experience With 37 Patients In South India

14 citations, September 2009 in “International Journal of Dermatology”

DCPA is a chronic leg infection often related to Staphylococcus aureus, affecting mostly young men in India.

research Dermatitis Cruris Pustulosa et Atrophicans

11 citations, January 2009 in “Indian journal of dermatology, venereology, and leprology”

DCPA is a chronic skin condition affecting the lower limbs, mainly in men, with unclear causes and treatments that often don't work well.

research Diphenylcyclopropenone-Induced Vitiligo in a Patient with Alopecia Universalis

4 citations, August 2013 in “Case reports in dermatology”

A patient with total hair loss developed vitiligo after using a treatment called DCP.

View more "dcp" in research →

Community Join

0 / 0 results

— no results